» Articles » PMID: 33762794

Perfluorobutanesulfonic Acid (PFBS) Induces Fat Accumulation in HepG2 Human Hepatoma

Overview
Specialty Chemistry
Date 2021 Mar 25
PMID 33762794
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Per- and poly-fluoroalkyl substances, especially perfluorooctanesulfonic acid, have been extensively used for over 50 years. A growing body of evidence has emerged demonstrating the potential adverse effects of these substances, including its effect on the development of non-alcoholic fatty liver disease, as one of the most prevalent chronic liver diseases. Nonetheless, there is no report of effects of perfluorobutanesulfonic acid, the major replacement for perfluorooctanesulfonic acid, on non-alcoholic fatty liver disease. Therefore, the effects of perfluorobutanesulfonic acid exposure on fat accumulation in a human hepatoma cell line were examined. Cells were exposed to perfluorobutanesulfonic acid with or without 300 μmol/L fatty acid mixture (oleic acid:palmitic acid = 2:1) conjugated by bovine serum albumin as an inducer of steatosis for 48 hours. Perfluorobutanesulfonic acid at 200 μmol/L significantly increased the triglyceride level in the presence of fatty acid compared to the control, but not without fatty acid, which was abolished by a specific peroxisome proliferator-activated receptor gamma antagonist. Perfluorobutanesulfonic acid upregulated key genes controlling lipogenesis and fatty acid uptake. Perfluorobutanesulfonic acid treatment also promoted the production of reactive oxygen species, an endoplasmic reticulum stress marker and cytosolic calcium. In conclusion, perfluorobutanesulfonic acid increased fat accumulation, in part, via peroxisome proliferator-activated receptor gamma-mediated pathway in hepatoma cells.

Citing Articles

Preconception exposure to perfluorooctanesulfonic acid (PFOS) and perfluorobutanesulfonic acid (PFBS) impaired reproduction via insulin/insulin-like growth factor signaling pathway without effects on the second generation in .

Li S, Yue Y, Qian Z, Teng Z, Clark J, Timme-Laragy A Toxicol Rep. 2025; 14:101966.

PMID: 40066201 PMC: 11891744. DOI: 10.1016/j.toxrep.2025.101966.


Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS).

Ehrlich V, Bil W, Vandebriel R, Granum B, Luijten M, Lindeman B Environ Health. 2023; 22(1):19.

PMID: 36814257 PMC: 9944481. DOI: 10.1186/s12940-022-00958-5.


Fatty acid tryptamide from cacao elongates Drosophila melanogaster lifespan with sirtuin-dependent heat shock protein expression.

Kanno K, Kayashima Y, Tamura K, Miyara T, Baba K, Koganei M Sci Rep. 2022; 12(1):12080.

PMID: 35840713 PMC: 9287426. DOI: 10.1038/s41598-022-16471-1.

References
1.
Qian Y, Ducatman A, Ward R, Leonard S, Bukowski V, Guo N . Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A. 2010; 73(12):819-36. PMC: 3107001. DOI: 10.1080/15287391003689317. View

2.
Park S, Scheffler T, Gunawan A, Shi H, Zeng C, Hannon K . Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle. Am J Physiol Cell Physiol. 2008; 296(1):C106-15. DOI: 10.1152/ajpcell.00114.2008. View

3.
Gerets H, Tilmant K, Gerin B, Chanteux H, Depelchin B, Dhalluin S . Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012; 28(2):69-87. PMC: 3303072. DOI: 10.1007/s10565-011-9208-4. View

4.
Siersbaek R, Nielsen R, Mandrup S . PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies. FEBS Lett. 2010; 584(15):3242-9. DOI: 10.1016/j.febslet.2010.06.010. View

5.
Yang B, Zou W, Hu Z, Liu F, Zhou L, Yang S . Involvement of oxidative stress and inflammation in liver injury caused by perfluorooctanoic acid exposure in mice. Biomed Res Int. 2014; 2014:409837. PMC: 3958804. DOI: 10.1155/2014/409837. View